All In MedTech

FDA Clearance Tracker · P930039-S263

CapSureFix Novus Lead, Vitatron Crystalline ActFix Lead, Vitatron Crystalline Active Fixation Lead

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: May 6, 2025 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

May 6, 2025

Approved

Time to decision

223 days

Received Sep 25, 2024. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track

Device class

Class III

The decision

FDA number
P930039-S263
Device name
CapSureFix Novus Lead, Vitatron Crystalline ActFix Lead, Vitatron Crystalline Active Fixation Lead
Applicant location
Mounds View, MN
Received
Sep 25, 2024
Decided
May 6, 2025
Decision
Approved
Supplement type
Normal 180 Day Track
Reason for supplement
Change Design/Components/Specifications/Material
Original approval
P930039

Device type

Device class
Class III

Every decision under product code NVN

FDA's approval statement

As written in FDA's record.

approval for the addition of an alternate supplier of polyurethane resin for use in tissue-contacting components in the CapSureFix Novus lead family

Source documents

Other decisions for Medtronic, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

5 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.